240 related articles for article (PubMed ID: 25572331)
1. RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment.
Nasser MW; Wani NA; Ahirwar DK; Powell CA; Ravi J; Elbaz M; Zhao H; Padilla L; Zhang X; Shilo K; Ostrowski M; Shapiro C; Carson WE; Ganju RK
Cancer Res; 2015 Mar; 75(6):974-85. PubMed ID: 25572331
[TBL] [Abstract][Full Text] [Related]
2. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
[TBL] [Abstract][Full Text] [Related]
3. cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment.
Mishra S; Charan M; Shukla RK; Agarwal P; Misri S; Verma AK; Ahirwar DK; Siddiqui J; Kaul K; Sahu N; Vyas K; Garg AA; Khan A; Miles WO; Song JW; Bhutani N; Ganju RK
J Exp Clin Cancer Res; 2022 Feb; 41(1):54. PubMed ID: 35135586
[TBL] [Abstract][Full Text] [Related]
4. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.
Kwak T; Drews-Elger K; Ergonul A; Miller PC; Braley A; Hwang GH; Zhao D; Besser A; Yamamoto Y; Yamamoto H; El-Ashry D; Slingerland JM; Lippman ME; Hudson BI
Oncogene; 2017 Mar; 36(11):1559-1572. PubMed ID: 27669433
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE.
Narumi K; Miyakawa R; Ueda R; Hashimoto H; Yamamoto Y; Yoshida T; Aoki K
J Immunol; 2015 Jun; 194(11):5539-48. PubMed ID: 25911757
[TBL] [Abstract][Full Text] [Related]
7. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.
Taguchi A; Blood DC; del Toro G; Canet A; Lee DC; Qu W; Tanji N; Lu Y; Lalla E; Fu C; Hofmann MA; Kislinger T; Ingram M; Lu A; Tanaka H; Hori O; Ogawa S; Stern DM; Schmidt AM
Nature; 2000 May; 405(6784):354-60. PubMed ID: 10830965
[TBL] [Abstract][Full Text] [Related]
8. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis.
Loeser RF; Yammani RR; Carlson CS; Chen H; Cole A; Im HJ; Bursch LS; Yan SD
Arthritis Rheum; 2005 Aug; 52(8):2376-85. PubMed ID: 16052547
[TBL] [Abstract][Full Text] [Related]
9. Central role of RAGE-dependent neointimal expansion in arterial restenosis.
Sakaguchi T; Yan SF; Yan SD; Belov D; Rong LL; Sousa M; Andrassy M; Marso SP; Duda S; Arnold B; Liliensiek B; Nawroth PP; Stern DM; Schmidt AM; Naka Y
J Clin Invest; 2003 Apr; 111(7):959-72. PubMed ID: 12671045
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.
Tafani M; Schito L; Pellegrini L; Villanova L; Marfe G; Anwar T; Rosa R; Indelicato M; Fini M; Pucci B; Russo MA
Carcinogenesis; 2011 Aug; 32(8):1167-75. PubMed ID: 21642357
[TBL] [Abstract][Full Text] [Related]
11. S100 to receptor for advanced glycation end-products binding assay: looking for inhibitors.
Padilla L; Dakhel S; Hernández JL
Biochem Biophys Res Commun; 2014 Mar; 446(1):404-9. PubMed ID: 24613850
[TBL] [Abstract][Full Text] [Related]
12. Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation.
Shubbar E; Vegfors J; Carlström M; Petersson S; Enerbäck C
Breast Cancer Res Treat; 2012 Jul; 134(1):71-80. PubMed ID: 22189627
[TBL] [Abstract][Full Text] [Related]
13. Increased Expression of the Receptor for Advanced Glycation End-Products (RAGE) Is Associated with Advanced Breast Cancer Stage.
Nankali M; Karimi J; Goodarzi MT; Saidijam M; Khodadadi I; Razavi AN; Rahimi F
Oncol Res Treat; 2016; 39(10):622-628. PubMed ID: 27710974
[TBL] [Abstract][Full Text] [Related]
14. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
Gu L; Hagiwara S; Fan Q; Tanimoto M; Kobata M; Yamashita M; Nishitani T; Gohda T; Ni Z; Qian J; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2006 Feb; 21(2):299-313. PubMed ID: 16263740
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
Mahajan N; Bahl A; Dhawan V
Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
[TBL] [Abstract][Full Text] [Related]
16. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.
Emberley ED; Niu Y; Curtis L; Troup S; Mandal SK; Myers JN; Gibson SB; Murphy LC; Watson PH
Cancer Res; 2005 Jul; 65(13):5696-702. PubMed ID: 15994944
[TBL] [Abstract][Full Text] [Related]
17. The receptor for advanced glycation end products is dispensable in a mouse model of oral and esophageal carcinogenesis.
Mark R; Bermejo JL; Bierhaus A; Plinkert PK; Angel P; Hess J
Histol Histopathol; 2013 Dec; 28(12):1585-94. PubMed ID: 23712426
[TBL] [Abstract][Full Text] [Related]
18. RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells.
Medapati MR; Dahlmann M; Ghavami S; Pathak KA; Lucman L; Klonisch T; Hoang-Vu C; Stein U; Hombach-Klonisch S
Thyroid; 2015 May; 25(5):514-27. PubMed ID: 25744544
[TBL] [Abstract][Full Text] [Related]
19. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.
Goova MT; Li J; Kislinger T; Qu W; Lu Y; Bucciarelli LG; Nowygrod S; Wolf BM; Caliste X; Yan SF; Stern DM; Schmidt AM
Am J Pathol; 2001 Aug; 159(2):513-25. PubMed ID: 11485910
[TBL] [Abstract][Full Text] [Related]
20. Role of receptor for advanced glycation end products in the complication and progression of various types of cancers.
Malik P; Chaudhry N; Mittal R; Mukherjee TK
Biochim Biophys Acta; 2015 Sep; 1850(9):1898-904. PubMed ID: 26028296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
